Evidence map›Paper›PMID 24790420›Full record

ArticleClinical interventions in aging2014

A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology.

Roberta Zappacosta, Giuseppe Lattanzio, Patrizia Viola, Manuel Maria Ianieri, Daniela Maria Pia Gatta, Sandra Rosini

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Clinical interventions in aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. HPV negative cervical cancers and primary HPV screening.Facts, views & vision in ObGyn · 2018
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Roberta ZappacostaCytopathology Unit, Experimental and Clinical Sciences Department, Gabriele d'Annunzio University of Chieti-Pescara, Chieti, Italy.
Giuseppe LattanzioSurgical Pathology Unit, SS Annunziata Hospital, Chieti, Italy.
Patrizia ViolaSurgical Pathology Unit, SS Annunziata Hospital, Chieti, Italy.
Manuel Maria IanieriObstetrics and Gynecology Unit, SS Annunziata Hospital, Chieti, Italy.
Daniela Maria Pia GattaCytopathology Unit, Experimental and Clinical Sciences Department, Gabriele d'Annunzio University of Chieti-Pescara, Chieti, Italy.
Sandra RosiniCytopathology Unit, Experimental and Clinical Sciences Department, Gabriele d'Annunzio University of Chieti-Pescara, Chieti, Italy.
Ospedale SS. Annunziata · ITUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The introduction of organized cervical cancer (CC) screening programs has drastically reduced the prevalence of CC. However the incidence is still too high, especially among elderly women. All guidelines strongly recommend a regular Papanicolaou (Pap) testing for young and middle-aged patients. On the other hand, many international professional societies no longer advise screening in women who have undergone hysterectomy, and in women aged 65 years and above, who have a previous history of regular Pap smears. Here we report the case of poorly differentiated CC, involving the pelvic lymph nodes and urinary bladder, occurring in a 79-year-old woman who regularly underwent Pap tests, with no reported cytological abnormalities. In this very rare case, the CC cells, as well as cells from metastatic lymph nodes and cells from urinary specimens, molecularly showed human papilloma virus (HPV)-53. With the limitations of a single case, this report brings important information to prevent CC in elderly patients: the utility of molecular tests to increase sensitivity of Pap smears in postmenopausal women; the importance of HPV-53 as one of the four "emergent" genotypes having a possible role in oncogenesis; and the presence of HPV-53 in lymph node metastases from cervical carcinoma, which would support the role of this virus in the maintenance of malignant status.

Indexed as

Papanicolaou TestPapillomaviridaeAgedCarcinoma, Squamous CellCervix UteriFalse Negative ReactionsFemaleHumansPapillomavirus InfectionsReal-Time Polymerase Chain ReactionUterine Cervical Neoplasmscervical cancer screeningHPV-DNA testHPV genotypingmolecular testsold women

Identifiers

PMID24790420
PMCPMC3998847
OpenAlexW2083854909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.